Can the golden nutraceutical frankincense combat COVID-19?

Keywords

COVID-19 / frankincense / resin

References

[1] Al-Harrasi, A., Hussain, H., Csuk, R., & Khan, H. Y. (2018a). Frankincense in modern medicine. In Chemistry and Bioactivity of Boswellic acids and other terpenoids of the genus Boswellia (pp. 127–136). Elsevier.

[2] Al-Harrasi, A., Hussain, H., Csuk, R., & Khan, H. Y. (2018b). Taxonomy of Boswellia Tree, traditional medicinal uses of frankincense and historical aspects of boswellic acids. In Chemistry and bioactivity of boswellic acids and other terpenoids of the genus Boswellia (pp. 1–7). Elsevier.

[3] Al-Harrasi, A., Rehman, N. U., Khan, A. L., Al-Broumi, M., Al-Amri, I., Hussain, J., Hussain, H., & Csuk, R. (2018). Chemical, molecular and structural studies of boswellia species: β-Boswellic aldehyde and 3-epi-11β-dihydroxy BA as precursors in biosynthesis of boswellic acids. PLoS One, 13, e0198666.

[4] Badria, F. A., Abu-Karam, M., Mikhaeil, B. R., Maatooq, G. T., & Amer, M. M. (2003). Anti-herpes activity of isolated compounds from frankincense. Biosciences, Biotechnology Research Asia, 1, 1–10.

[5] Bergmann, J. (2004). Untersuchungen zum Harz des Weihrauchbaums (Boswellia spp.) unter besonderer Berücksichtigung der Säurefraktion [Dissertation], Techn. Univ. München.

[6] Efferth, T., & Oesch, F. (2022). Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities. Seminars in Cancer Biology, 80, 39–57.

[7] Gebrehiwot, K., Muys, B., Haile, M., & Mitloehner, R. (2003). Introducing Boswellia papyrifera (Del.) Hochst and its non-timber forest product, frankincense. International Forestry Review, 5(2003), 348–353.

[8] Gomaa, A. A., Mohamed, H. S., Abd-Ellatief, R. B., & Gomaa, M. A. (2021). Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly. Inflammopharmacology, 29(4), 1033–1048.

[9] Gomaa, A. A., Mohamed, H. S., Abd-ellatief, R. B., Gomaa, M. A., & Hammam, D. S. (2022). Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: A randomized clinical trial. Inflammopharmacology, 30(2), 477–486.

[10] Hawkins, J., Hires, C., Keenan, L., & Dunne, E. (2022). Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial. Complementary Therapies in Medicine, 67, 102823.

[11] Hussain, H., Al-Harrasi, A., Csuk, R., Shamraiz, U., Green, I. R., Ahmed, I., Khan, I. A., & Ali, Z. (2017). Therapeutic potential of boswellic acids: A patent review (1990-2015). Expert Opinion on Therapeutic Patents, 27(1), 81–90.

[12] Hussain, H., Rashan, L., Hassan, U., Abbas, M., Hakkim, F. L., & Green, I. R. (2022). Frankincense diterpenes as a bio-source for drug discovery. Expert Opinion on Drug Discovery, 17(5), 513–529.

[13] Jamshidi, Z., Hashemi, M., Yazdian-Robati, R., Etemad, L., Salmasi, Z., & Kesharwani, P. (2022). Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2. Inflammopharmacology, 30(5), 1541–1553.

[14] Kadhim, M. M., Salman, A. W., Zarzoor, A. M., & Kadhum, W. R. (2021). Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study. Journal of Molecular Liquids, 337, 116440.

[15] Sabra, S. M. M., & Ahmad, S. E. A. (2022). Using frankincense-soak as Saudi-habit for eliminating the microbial-causes of respiratory-tract during corona-pandemic. Journal of Biomed Research, 2(2022), 1–4.

[16] Todd, S. B., Riazi, A., Zhang, Y., Karima, S., Tafakhori, A., Baram, S. M., Mokhtari, F., Salehi, M. R., & Rad, N. K. (2021). Immunomodulatory and antiviral action of boswellia gum resin extracts, derived formulations, and boswellic acids against respiratory viruses and uses thereof. WO2021217275A1.

RIGHTS & PERMISSIONS

2024 The Authors. Future Postharvest and Food published by John Wiley & Sons Australia, Ltd on behalf of International Association of Dietetic Nutrition and Safety.